Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $681.00 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $213.29 | 11 | $0 (2024) |
| Novo Nordisk Inc | $112.08 | 6 | $0 (2024) |
| Amgen Inc. | $107.21 | 1 | $0 (2021) |
| PFIZER INC. | $95.83 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $30.98 | 2 | $0 (2023) |
| Abbott Laboratories | $28.91 | 2 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $25.78 | 1 | $0 (2021) |
| Astellas Pharma US Inc | $14.46 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $13.76 | 1 | $0 (2021) |
| Lilly USA, LLC | $13.22 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $113.50 | 7 | PFIZER INC. ($53.74) |
| 2023 | $129.43 | 8 | ABBVIE INC. ($43.58) |
| 2022 | $200.36 | 10 | ABBVIE INC. ($105.31) |
| 2021 | $237.71 | 9 | Amgen Inc. ($107.21) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Biological | ||||||
| 09/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: VACCINES | ||||||
| 08/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/13/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Diabetes | ||||||
| 10/09/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.46 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2023 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: VACCINES | ||||||
| 10/06/2023 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: VACCINES | ||||||
| 06/21/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Obesity | ||||||
| 05/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Diabetes | ||||||
| 01/09/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug), LIVALO | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/29/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $40.12 | General |
| Category: Obesity | ||||||
| 09/19/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
| 08/19/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Diabetes Care | ||||||
| 02/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 223 | 416 | $18,501 | $4,997 |
| 2022 | 11 | 355 | 586 | $25,342 | $6,500 |
| 2021 | 10 | 308 | 553 | $24,497 | $6,003 |
| 2020 | 10 | 256 | 408 | $18,159 | $4,400 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 47 | 89 | $5,410 | $1,465 | 27.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 47 | 107 | $4,655 | $1,107 | 23.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 46 | 104 | $2,496 | $791.44 | 31.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 15 | 23 | $3,000 | $667.23 | 22.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 43 | $1,505 | $409.36 | 27.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 27 | 29 | $1,160 | $380.48 | 32.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 21 | $275.00 | $176.40 | 64.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 52 | 99 | $6,369 | $1,633 | 25.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 66 | 135 | $6,184 | $1,410 | 22.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 67 | 147 | $3,528 | $1,129 | 32.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 40 | 42 | $1,716 | $555.57 | 32.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 28 | 52 | $1,906 | $499.43 | 26.2% |
| 82306 | Vitamin d-3 level | Office | 2022 | 14 | 16 | $2,310 | $467.96 | 20.3% |
| 87389 | Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies | Office | 2022 | 12 | 12 | $396.00 | $286.08 | 72.2% |
| 86803 | Hepatitis c antibody measurement | Office | 2022 | 16 | 16 | $1,344 | $225.75 | 16.8% |
| 82043 | Urine microalbumin (protein) level | Office | 2022 | 20 | 23 | $790.00 | $131.68 | 16.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 20 | 22 | $535.00 | $113.01 | 21.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 20 | 22 | $264.00 | $49.05 | 18.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 46 | 96 | $6,376 | $1,613 | 25.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 63 | 133 | $6,306 | $1,401 | 22.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 59 | 139 | $3,336 | $1,080 | 32.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 27 | 59 | $2,225 | $572.89 | 25.7% |
| 82306 | Vitamin d-3 level | Office | 2021 | 13 | 18 | $2,655 | $532.80 | 20.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 37 | 39 | $1,631 | $522.21 | 32.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2021 | 14 | 14 | $523.00 | $80.92 | 15.5% |
About Kelly Ragaller, ARNP
Kelly Ragaller, ARNP is a Nurse Practitioner healthcare provider based in South Sioux City, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801992532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelly Ragaller, ARNP has received a total of $681.00 in payments from pharmaceutical and medical device companies, with $113.50 received in 2024. These payments were reported across 34 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($681.00).
As a Medicare-enrolled provider, Ragaller has provided services to 1,142 Medicare beneficiaries, totaling 1,963 services with total Medicare billing of $21,901. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family
- Location South Sioux City, NE
- Active Since 09/16/2006
- Last Updated 05/13/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1801992532
Products in Payments
- Repatha (Biological) $107.21
- UBRELVY (Drug) $104.70
- QULIPTA (Drug) $62.35
- VRAYLAR (Drug) $46.24
- Ozempic (Drug) $43.95
- Saxenda (Drug) $40.12
- ELIQUIS (Drug) $30.11
- TRUMENBA (Biological) $28.65
- NURTEC ODT (Drug) $25.78
- PREVNAR 20 (Biological) $23.63
- REXULTI (Drug) $17.33
- FreeStyle Libre 2 (Device) $14.47
- Veozah (Drug) $14.46
- FREESTYLE LIBRE 2 (Device) $14.44
- Rybelsus (Drug) $14.12
- Wegovy (Drug) $13.89
- GARDASIL 9 (Biological) $13.76
- ABILIFY MAINTENA (Drug) $13.65
- PREMARIN (Drug) $13.44
- MOUNJARO (Drug) $13.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.